RESUMEN
A 67-year-old man presented with a complaint of a painful nodule on his back for approximately two months. On exam, a violaceous, firm, warm, indurated nodule measuring 3.5 x 2 cm was observed. Nine months prior to presentation, he was diagnosed with a moderately differentiated squamous cell carcinoma (SCC) of the left upper lobe (stage 1b), which was removed via video-assisted thoracoscopic wedge resection. Diagnosis of metastatic SCC secondary to traumatic seeding at a trocar port site was made. To our knowledge, this has not been previously described in the literature.
Asunto(s)
Carcinoma de Células Escamosas/secundario , Neoplasias Pulmonares/patología , Neoplasias Cutáneas/secundario , Anciano , Dorso/patología , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/cirugía , Humanos , Neoplasias Pulmonares/cirugía , Masculino , Siembra Neoplásica , Neoplasias Cutáneas/diagnóstico , Toracoscopía/instrumentaciónAsunto(s)
Actitud Frente a la Salud/etnología , Grupos Minoritarios/estadística & datos numéricos , Salud de las Minorías/etnología , Neoplasias Cutáneas/epidemiología , Adulto , Negro o Afroamericano/estadística & datos numéricos , Anciano , Pueblo Asiatico/estadística & datos numéricos , Concienciación , Estudios Transversales , Escolaridad , Femenino , Conocimientos, Actitudes y Práctica en Salud , Hispánicos o Latinos/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Ciudad de Nueva York/epidemiología , Características de la Residencia , Neoplasias Cutáneas/diagnóstico , Pigmentación de la Piel , Factores Socioeconómicos , Población Blanca/estadística & datos numéricos , Adulto JovenRESUMEN
PURPOSE OF REVIEW: Acne vulgaris is a common skin condition that affects approximately 40-50 million Americans annually. The peak incidence of acne occurs during adolescence and young adulthood, with approximately 80% of persons aged 11-30 years having at least minor acne. Because the onset of acne is typically in early adolescence, pediatricians are often at the front-lines in terms of caring for patients with this chief complaint. RECENT FINDINGS: Over the last 2 years, new acne therapies have become available. These include new combination fixed-dose products, which may allow for greater flexibility in treatment and greater patient compliance. New topical antibiotics have also come to the market, providing more therapeutic options for mild to moderate inflammatory acne. Lastly, acne therapies involving the use of light sources and photosensitizers are currently being developed, which may provide a whole new modality for managing complicated patients. SUMMARY: Successful management of acne requires the physician to make a thorough assessment of the patient's acne severity, predominant lesion type, skin type, and lifestyle in order to pair each individual patient's needs with the appropriate anti-acne therapy. This article provides an overview of the pathophysiology of acne and pre-existing topical therapies. It then discusses some novel acne therapies and outlines how they might fit into a physician's treatment strategy.